These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34760892)

  • 1. Tumor Suppressor FBXW7 and Its Regulation of DNA Damage Response and Repair.
    Lan H; Sun Y
    Front Cell Dev Biol; 2021; 9():751574. PubMed ID: 34760892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights and clinical implications for the tumor suppressor role of SCF
    Qi Y; Rezaeian AH; Wang J; Huang D; Chen H; Inuzuka H; Wei W
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189140. PubMed ID: 38909632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent insight into the role of FBXW7 as a tumor suppressor.
    Yumimoto K; Nakayama KI
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXW7: a critical tumor suppressor of human cancers.
    Yeh CH; Bellon M; Nicot C
    Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXW7 Confers Radiation Survival by Targeting p53 for Degradation.
    Cui D; Xiong X; Shu J; Dai X; Sun Y; Zhao Y
    Cell Rep; 2020 Jan; 30(2):497-509.e4. PubMed ID: 31940492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development.
    de la Cova CC
    Cells; 2023 Aug; 12(17):. PubMed ID: 37681873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity.
    Lan H; Tan M; Zhang Q; Yang F; Wang S; Li H; Xiong X; Sun Y
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12311-12320. PubMed ID: 31152129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXW7 in Cancer: What Has Been Unraveled Thus Far?
    Sailo BL; Banik K; Girisa S; Bordoloi D; Fan L; Halim CE; Wang H; Kumar AP; Zheng D; Mao X; Sethi G; Kunnumakkara AB
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30791487
    [No Abstract]   [Full Text] [Related]  

  • 10. The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.
    Zhang Q; Mady ASA; Ma Y; Ryan C; Lawrence TS; Nikolovska-Coleska Z; Sun Y; Morgan MA
    Nucleic Acids Res; 2019 May; 47(8):4039-4053. PubMed ID: 30722038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics and roles of β-TrCP1/2 in carcinogenesis.
    Bi Y; Cui D; Xiong X; Zhao Y
    FEBS J; 2021 Jun; 288(11):3351-3374. PubMed ID: 33021036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of FBXW7 loss of function in human cancers.
    Fan J; Bellon M; Ju M; Zhao L; Wei M; Fu L; Nicot C
    Mol Cancer; 2022 Mar; 21(1):87. PubMed ID: 35346215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCF
    Sugiyama S; Yumimoto K; Inoue I; Nakayama KI
    Genes Cells; 2019 May; 24(5):354-365. PubMed ID: 30838725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of BRAF protein stability by a negative feedback loop involving the MEK-ERK pathway but not the FBXW7 tumour suppressor.
    Hernandez MA; Patel B; Hey F; Giblett S; Davis H; Pritchard C
    Cell Signal; 2016 Jun; 28(6):561-71. PubMed ID: 26898828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients.
    Hagedorn M; Delugin M; Abraldes I; Allain N; Belaud-Rotureau MA; Turmo M; Prigent C; Loiseau H; Bikfalvi A; Javerzat S
    Cell Div; 2007 Feb; 2():9. PubMed ID: 17326833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
    Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
    Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
    J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer.
    Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C
    Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy.
    Chen S; Lin J; Zhao J; Lin Q; Liu J; Wang Q; Mui R; Ma L
    Front Oncol; 2023; 13():1147239. PubMed ID: 36998461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.